A new and novel treatment for POSTPARTUM DEPRESSION has just been introduced and is indicated for severe refractory PPD. Derived from the natural steroid hormone, allopregnanolone, this novel steroid acts directly in the brain to reduce depression. Its only problem is that it requies a 60 hour IV infusion of drug in a clinical environment. Studies show it is highly effective. Again, its indicated for SEVERE refractory PPD.
Results are in!!! What did we find out from 4,455 moms who chose to vaccinate while breastfeeding?
Find out the full story here: https://doi.org/10.1089/bfm.2021.0079
McLaurin-Jiang S, Garner CD, Krutsch K, Hale TW. Maternal and Child Symptoms Following COVID-19 Vaccination Among Breastfeeding Mothers [published online ahead of print, 2021 Jun 25]. Breastfeed Med. 2021;10.1089/bfm.2021.0079. doi:10.1089/bfm.2021.0079
Below is an interesting article characterizing transfer of Corona Virus to infant in perinatal period. Maybe we don't need to separate moms and babies... TWH
Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis
Everyone has been concerned about the presence of Covid-19 in human milk. Several other studies as well as this one have found Covid-19 in human milk. This is the first article I've seen that also studied its ability to induce infection. The covid in these milk samples was apparently not infectious.
Abilify is really popular for treating bipolar symptoms and psychosis, particularly because it causes the least weight gain in patients.
That said, I continue to warn that the use of this product in breastfeeding mothers is HIGHLY likely to suppress prolactin production and therefore milk production.
I see many comments of women who just stop Abilify and go without support of this fine drug.
It is important to remember, that if you need one of these mood stabilizers there are other su
7/29/2019 FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections | The U.S. Food and Drug Administration has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial drug product to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).